Potential preventive effects of coenzyme Q and creatine supplementation on brain energy metabolism in rats exposed to chronic cerebral hypoperfusion

Systems Biology of Free Radicals and Antioxidants

Volumn , Issue , 2012, Pages 2033-2048

  Aliev, Gjumrakch ^a,b   Ashraf, Ghulam Md ^c   Horecký, Jaromir ^d   Vančová, Olga ^e   Gvozdjáková, Anna ^e   Kucharská, Jarmila ^e   Palacios, Hector H ^f   Li, Yi ^g   Perveen, Asma ^h   Khan, Taqi Ahmed ^h   Bragin, Valentin ⁱ   Bragin, Ilya ^j   Shevtsova, Elena ^k   Klochkov, Sergey G ^k   Kosenko, Elena A ^l   Cacabelos, Ramon ^m   Kaminsky, Yury G ^l   Sudakov, Konistantin V ^n,o   Benberin, Valery V ^p   Bachurin, Sergey O ^k  

^a GALLY International Biomedical Research Consulting LLC   (United States)

^b University of Atlanta   (United States)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^e Bratislava   (Slovakia)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ALIGARH MUSLIM UNIVERSITY   (India)

ⁱ Stress Relief and Memory Training Center   (United States)

^j SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^k INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^l INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^m CAMILO JOSÉ CELA UNIVERSITY   (Spain)

ⁿ P K ANOKHIN INSTITUTE OF NORMAL PHYSIOLOGY   (Russian Federation)

^o I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^p Medical Center of the Administration of the President of the Republic of Kazakhstan   (Kazakhstan)

more..

Author keywords

^{31< sup>P MRS; Coenzyme Q10; Creatine; Endogenous antioxidants; OXPHOS; Three vessel occlusion; Vascular dementia}

Indexed keywords

EID: 84929138300     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-30018-9_204     Document Type: Chapter

References (45)

1. Aliev G (2011) Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future. CNS Neurol Disord Drug Targets 10:147-148
2. Aliev G, Gasimov E, Obrenovich ME et al (2008a) Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease. Vasc Health Risk Manag 4:721-730
3. Aliev G, Liu J, Shenk JC et al (2009c) Neuronal mitochondrial amelioration by feeding acetyl-Lcarnitine and lipoic acid to aged rats. J Cell Mol Med 13(2):320-333
4. Aliev G, Obrenovich ME, Reddy VP et al (2008b) Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev Med Chem 8:1395-1406
5. Aliev G, Palacios HH, Lipsitt AE et al (2009b) Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotox Res 16:293-305
6. Aliev G, Palacios HH, Walrafen B et al (2009a) Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int J Biochem Cell B 41:1989-2004
7. Aliev G, Smith MA, de la Torre JC, Perry G (2004) Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion 4:649-663
8. Ames BN, Shigenaga MK, Hagen TM (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90:7915-7922
9. Candelario-Jalil E, Mhadu NH, Al-Dalain SM et al (2001) Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci Res 41:233-241
10. Chan PH (2001) Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cerebr Blood F Met 21:2-14
11. Crane FL, Navas P (1997) The diversity of coenzyme Q function. Mol Aspects Med 18:S1-S6
12. de la Torre JC (1999) Critical threshold cerebral hypoperfusion causes Alzheimer's disease? Acta Neuropathol 98:1-8
13. de la Torre JC, Fortin T, Park GA et al (1993) Brain blood flow restoration 'rescues' chronically damaged rat CA1 neurons. Brain Res 623:6-15
14. Frank L, Massaro D (1980) Oxygen-toxicity. Am J Med 69:117-126
15. Halliwell B, Gutteridge JMC (1985) Oxygen radicals and the nervous system. Trends Neurosci 8:22-26
16. Horecký J, Aliev G, Gvozdjáková A et al (2010) Preventive and therapeutic coenzyme Q10 supplementation in rat subjected to cerebrovascular ischemia-reperfusion injury. Curr Neurobiol 1(1):30-36
17. Horecký J, Baciak L, Vancová O et al (2006) Effects of transient ischemia on rat brain energy metabolism assessed in vivo by 31P MRS and in vitro by mitochondrial OX-PHOS. Biochim Biophys Acta -Bioenerg S:178-179
18. Horecký J, Baciak L, Pacheco G et al (2009) Minimally invasive surgical approaches for threevessel occlusion as a model of vascular dementia in the rat brain bioenergetics assay. J Neurol Sci 283(1-2):178-181
19. Horecký J, Gvozdjáková A, Kucharská J et al (2011) Effects of coenzyme Q and creatine supplementation on brain energy metabolism in rats exposed to chronic cerebral hypoperfusion. Curr Alzheimer Res 8:868-875
20. James AM, Smith RAJ, Murphy MP (2004) Antioxidant and prooxidant properties of mitochondrial coenzyme Q. Arch Biochem Biophys 423:47-56
21. Janero DR, Burghardt B (1989) Thiobarbituric acid-reactive malondialdehyde formation during superoxide-dependent, iron-catalyzed lipid peroxidation: influence of peroxidation conditions. Lipids 24:125-131
22. Jenkins LW, Povlishock JT, Lewelt W et al (1981) The role of post-ischemic recirculation in the development of ischemic neuronal injury following complete cerebral ischemia. Acta Neuropathol 55:205-220
23. Kogure K, Arai H, Abe K, Nakano M(1985) Free-radical damage of the brain following ischemia. Prog Brain Res 63:237-259
24. Kucharska J, Gvozdjáková A, Mizera S et al (1998) Participation of coenzyme Q10 in the rejection development of the transplanted heart: A clinical study. Physiol Res 47:399-404
25. Kwong LK, Kamzalov S, Rebrin I et al (2002) Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic Bio Med 33:627-638
26. Lang JK, Gohil K, Packer L (1986) Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem 157:106-116
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
28. Mori T, Asano T, Matsui T et al (1999) Intraluminal increase of superoxide anion following transient focal cerebral ischemia in rats. Brain Res 816:350-357
29. Obrenovich ME, Li Y, Parvathaneni K et al (2011) Antioxidants in health, disease and aging. CNS Neurol Disord Drug Targets 10:192-207
30. Obrenovich ME, Nair NG, Beyaz A et al (2010) The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res 13:631-643
31. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
32. Ohtsuki S, Tachikawa M, Takanaga T et al (2002) The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J Cereb Blood Flow Metab 22:1327-1335
33. Palacios HH, Yendluri BB, Parvathaneni K et al (2011)Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease. CNS Neurol Disord Drug Targets 10:149-162
34. Persky AM, Brazeau GA, Hochhaus G (2003) Pharmacokinetics of the dietary supplement creatine. Clin Pharmacokinet 42:557-574
35. Pulsinelli WA, Brierley JB, Plum F (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11:491-498
36. Sarma JS, Ikeda S, Fischer R et al (1976) Biochemical and contractile properties of heart muscle after prolonged alcohol administration. J Mol Cell Cardiol 8:951-972
37. Sciamanna MA, Lee CP (1993) Ischemia/reperfusion-induced injury of forebrain mitochondria and protection by ascorbate. Arch Biochem Biophys 305:215-224
38. Schmidt-Kastner R, Freund TF (1991) Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 40:599-636
39. Shenk JC, Liu J, Fischbach K et al (2009) The effect of acetyl-L-carnitine and R-Alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. J Neurol Sci 283:199-206
40. Sims NR, Pulsinelli WA (1987) Altered mitochondrial respiration in selectively vulnerable brain subregions following transient forebrain ischemia in the rat. J Neurochem 49:1367-1374
41. Snow RJ, Murphy RM (2001) Creatine and the creatine transporter: A review. Mol Cell Biochem 224:169-181
42. Turunen M, Olsson J, Dallner G (2004) Metabolism and function of coenzyme Q. Biomembranes 1660:171-199
43. Vancová O, Baciak L, Kašparová S et al (2010) In vivo and in vitro assessment of brain bioenergetics in aging rats. J Cell Mol Med 14:2667-2674
44. Zhang YY, Aberg F, Appelkvist EL et al (1995) Uptake of dietary coenzyme-Q supplement is limited in rats. J Nutr 125:446-453
45. Zhang YY, Turunen M, Appelkvist EL (1996) Restricted uptake of dietary coenzyme Q is in contrast to the unrestricted uptake of alpha-tocopherol into rat organs and cells. J Nutr 126:2089-2097